← Back
$MURA All transactions

Mural Oncology plc

▼ SELL 10b5-1 Plan

$ Value

$30K

Shares

12,531

Price

$2

Filed

Jul 9

Insider

Name

Loew Caroline

Title

Chief Executive Officer

CIK

0001989488

Roles

Director Officer

Transaction Details

Transaction Date

2025-07-07

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

293,059

Footnotes

Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on December 14, 2023. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement that includes a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 that was entered into on March 27, 2024, and the sale does not represent a discretionary trade by the Reporting Person. | The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.43 to $2.53. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Includes 220,148 restricted stock units.

Filing Info

Accession No.

0000950170-25-094831

Form Type

4

Issuer CIK

0001971543

Loew Caroline's History

Date Ticker Type Value
2025-12-05 MURA D
2025-12-05 MURA D
2025-12-05 MURA D
2025-12-05 MURA D
2025-07-07 MURA $30K

Other Insiders at MURA (90d)

No other insider activity at this issuer in the last 90 days.